Johnathan Perry, MD
Orthopaedic Surgery · Kennewick, WANPI 1467433706
Payments from drug & device makers
What this record shows
The money is spread across several categories — education (51.3%), food and beverage and travel and lodging — rather than concentrated in one kind of arrangement. Summit Surgical Corp. accounts for 74.0% of it on its own, with 9 other manufacturers making up the rest. Reporting peaked in 2021 at $1,311 and has fallen 84.3% since, to $206 in 2025. That places this record below the midpoint for orthopaedic surgery clinicians in WA, where the typical reported total is $2,959.
Across 16 payments — averaging $148.81 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Summit Surgical Corp.$2K
- Arthrex$231
- Davol Inc.$130
- Vericel Corporation$66
- Stryker$56
- Johnson & Johnson$42
- plus $95 from 4 others
What the payments were for
- Travel & lodging$56224%
- Food & beverage$59825%
- Education$1,22151%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Summit Surgical Corp. | 2 | $1,762 |
| Arthrex | 3 | $231 |
| Davol Inc. | 1 | $130 |
| Vericel Corporation | 3 | $66 |
| Stryker | 1 | $56 |
| Johnson & Johnson | 2 | $42 |
| Bioventus LLC | 1 | $28 |
| Convatec Inc. | 1 | $25 |
| Invictus Surgical Incorporated | 1 | $24 |
| Ferring Pharmaceuticals Inc. | 1 | $18 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Phasix Mesh$130
How this compares
$2,381 in reported general payments places this provider in the 45th percentile of 495 orthopaedic surgery providers in Washington.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 36 | $416 |
| Ondansetron Hcl | 46 | $113 |
| Cephalexin | 28 | $31 |
| Meloxicam | 13 | $18 |
Paid to pharmacies, not to this prescriber.
Other orthopaedic surgery in Kennewick
- William BarrettRenton$7.7M
- James PritchettSeattle$6.4M
- James CrutcherSeattle$3.5M
- Keith MayoSeattle$3.1M
- Matthew SaltzmanSeattle$1.8M
- Tim LovellSpokane$1.8M
- Timothy AltonRenton$1.5M
- Burt YaszaySeattle$1.3M
- Sean ToomeySeattle$1.2M
- Richard WilliamsonMount Vernon$1.1M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.